Related by context. All words. (Click for frequent words.) 76 bone marrow suppression 76 hematologic toxicity 74 renal toxicity 73 nephrotoxic 73 myopathy rhabdomyolysis 73 systemic toxicity 73 β blockers 73 adrenal suppression 73 metabolic acidosis 73 pharmacokinetic interactions 73 tumor lysis syndrome 72 hypercalcemia 72 thromboembolic events 72 corticosteroid therapy 72 hematological toxicity 72 CYP #A# 72 intracranial hemorrhage ICH 72 hepatic toxicity 71 cardiac toxicity 71 myelosuppression 71 rFVIIa 71 EXJADE 71 delayed CINV 71 posaconazole 71 MULTAQ 71 Toxicities 71 hyperprolactinemia 71 hepatotoxicity 71 hemorrhagic complications 71 hypoperfusion 71 hypomagnesemia 71 transaminase elevations 71 Neutropenia 71 systemic corticosteroid 71 erythropoietic 71 vWF 71 rebleeding 71 intravenous bisphosphonates 71 neutropenic patients 71 upper gastrointestinal bleeding 71 trimethoprim sulfamethoxazole 70 gemifloxacin 70 intravascular hemolysis 70 leucopenia 70 severe hypersensitivity reactions 70 thrombotic events 70 gastrointestinal toxicity 70 dose dependently 70 bezafibrate 70 myeloperoxidase 70 eosinophilia 70 serum phosphate 70 systemic hypotension 70 neointimal hyperplasia 70 tryptase 70 cytopenias 70 Hypotension 70 calcineurin inhibitors 70 mycophenolate mofetil 70 hyperalgesia 70 aminotransferases 70 fibrinolytic 70 invasive candidiasis 70 serum urate levels 70 candidemia 70 HMG CoA reductase inhibitors 70 ß blockers 70 aspartate aminotransferase 70 hyperkalemia 70 elevated ALT 70 thrombotic complications 70 Thrombocytopenia 70 TNF antagonist 70 torsade de pointes 70 cerebral ischemia 69 AST ALT 69 nephrotoxic drugs 69 hyperphenylalaninemia HPA due 69 pancytopenia 69 dosing frequency 69 antitumor efficacy 69 severe neutropenia 69 inducible nitric oxide synthase 69 hypersensitivity reaction 69 fibrin deposition 69 mitochondrial toxicity 69 Natalizumab 69 esophageal candidiasis 69 VAPRISOL 69 Erythropoietic therapies may 69 haematologic 69 platelet activation 69 CMV infection 69 riociguat 69 chloride secretion 69 hepatocellular 69 amifostine 69 bacteriuria 69 phototoxicity 69 anterior uveitis 69 voriconazole 69 amphotericin B 69 hypotensive 69 antitumor effect 69 endometrial hyperplasia 69 deferiprone 69 paricalcitol 69 cytotoxic effects 69 heparin induced thrombocytopenia 69 glomerular filtration 69 recurrent glioblastoma multiforme 69 bleomycin 69 IL 1ß 69 isoproterenol 69 tardive dyskinesia TD 69 platelet inhibition 69 pulmonary infiltrates 69 cobiprostone 69 QTc prolongation 69 SGPT 69 renal dysfunction 69 pentoxifylline 69 aspartate aminotransferase AST 69 β blocker 69 TMP SMX 69 hypercalcaemia 69 cardiotoxicity 69 invasive aspergillosis 69 cardiotoxic 69 SSc 69 alkylating agent 68 postoperative morbidity 68 hemorrhagic cystitis 68 macrolide antibiotic 68 APTIVUS r 68 CsA 68 nitrofurantoin 68 platelet reactivity 68 mucosal inflammation 68 COPD exacerbations 68 serum calcium levels 68 neutropaenia 68 hepatorenal syndrome 68 coagulopathy 68 anemia thrombocytopenia 68 thrombocytopenia neutropenia 68 Angioedema 68 alpha interferons 68 QT interval prolongation 68 cerebral vasospasm 68 autoantibody levels 68 Torsades de Pointes 68 Hematologic toxicity 68 lichen planus 68 lymphopenia 68 primidone 68 KETEK 68 hypophosphatemia 68 hemodilution 68 hyperammonemia 68 plasma kallikrein inhibitor 68 salmeterol fluticasone 68 adrenal insufficiency 68 elevated intraocular pressure 68 Dasatinib 68 TNF Tumor Necrosis Factor 68 mycophenolic acid 68 mitomycin C 68 sotalol 68 myocardial reperfusion 68 strong CYP#A# inducers 68 hypercholesterolaemia 68 allograft rejection 68 HBeAg seroconversion 68 xanthine oxidase inhibitor 68 Candida infections 68 transgene expression 68 Febrile neutropenia 68 Candida infection 68 TORISEL 68 eosinophil count 68 CIMZIA ™ 68 steroid dexamethasone 68 sitaxsentan 68 antimuscarinic 68 coadministration 68 cinacalcet 68 indinavir 68 Oral corticosteroids 68 symptomatic VTE 68 fluvastatin 68 neutrophil counts 68 pamidronate 68 hyperglycaemia 68 HER2 overexpression 68 artery stenosis 68 serum urate 68 ursodeoxycholic acid 68 PAOD 68 endothelial activation 68 renal insufficiency 68 peripheral neuropathy CIPN 68 NSAID induced 68 microglial activation 68 Ribavirin causes 68 TNF α 67 hepatic insufficiency 67 DFMO 67 CYP3A 67 plasma pharmacokinetics 67 symptomatic intracranial hemorrhage 67 acute GvHD 67 dexrazoxane 67 Aliskiren 67 hepatotoxic 67 immunomodulatory effects 67 immunosuppressive agents 67 Cyclosporine 67 alanine aminotransferase 67 thrombocytosis 67 prolonged QT interval 67 microvascular complications 67 overlapping toxicities 67 neovascular 67 nicardipine 67 variceal bleeding 67 tolvaptan 67 indomethacin 67 serum phosphate levels 67 induce orthostatic hypotension 67 salmeterol HFA MDI 67 invasive fungal infections 67 NAbs 67 secondary hyperparathyroidism 67 Hypokalemia 67 antiproliferative 67 imatinib therapy 67 pheochromocytoma 67 docetaxel Taxotere ® 67 neutropenia dehydration dyspnea 67 caspofungin 67 endophthalmitis 67 serum LDL cholesterol 67 systemic corticosteroids 67 nicotinic acid 67 postoperative AF 67 Tacrolimus 67 hepatic enzymes 67 lenalidomide dexamethasone 67 ocular toxicity 67 HMG CoA reductase inhibitor 67 colorectal liver metastases 67 inotropes 67 Infusion Reactions Severe 67 lung fibrosis 67 autoimmune reactions 67 serum cortisol 67 colorectal adenoma 67 refractory gout 67 opioid analgesia 67 p# activation 67 fluid overload 67 reperfusion injury 67 systemic absorption 67 febrile neutropenia 67 fibrotic disease 67 heparanase 67 severe oral mucositis 67 potentially hepatotoxic 67 oxcarbazepine 67 dysmenorrhoea 67 transaminases 67 gastrointestinal perforation 67 parasitemia 67 arterial thrombosis 67 granulomatous 67 interferon IFN 67 INCB# [003] 67 alteplase 67 acitretin 67 lymphadenopathy 67 lactate dehydrogenase LDH 67 Itraconazole 67 aminotransferase 67 cranial irradiation 67 vasodilatation 67 Akt activation 67 abacavir lamivudine 67 adalimumab Humira 67 thromboembolic complications 67 teriflunomide 67 endotoxemia 67 vasodilators 67 NAGS deficiency 67 symptomatic hypotension 67 metastatic neuroendocrine tumors 67 HBeAg 67 pimozide 67 palifermin 67 flutamide 67 efalizumab 67 AA Amyloidosis 67 somatostatin analogs 67 symptomatic intracranial 67 toxicities 67 acute gout flares 67 proliferative diabetic retinopathy 67 chemotherapy induced neutropenia 67 Nilotinib 67 Eltrombopag 67 levodopa carbidopa 67 choroidal neovascularization CNV 67 LHRH agonists 67 d4T stavudine Zerit 67 coronary stenosis 67 cytoprotective 67 PDE4 inhibitors 67 serum HBV DNA 67 CP CPPS 67 IFN beta 67 haematological toxicity 67 antiarrhythmic 67 osteolytic 67 thromboembolic disease 67 Hepatotoxicity 67 MGd 67 inflammatory lesions 67 NMDA antagonists 67 ximelagatran 67 receiving XGEVA 67 uric acid lowering 67 pyrazinamide 67 metastatic malignant 67 fosamprenavir 67 vasodilatory 66 NSAID therapy 66 ATACAND 66 antimicrobial prophylaxis 66 extrapyramidal symptoms 66 oral prodrug 66 angiotensin converting enzyme inhibitors 66 Pioglitazone 66 myelodysplastic myeloproliferative diseases 66 plasminogen activators 66 ALT flares 66 tipranavir 66 micafungin 66 HbF 66 lowering blood glucose 66 skeletal metastases 66 hallucinations dyskinesia 66 pyridostigmine 66 serum phosphorous 66 VEGF inhibitors 66 olmesartan 66 FluCAM arm 66 occlusive disease 66 Mitoxantrone 66 anaphylactoid reactions 66 EGFRIs 66 grade cervical intraepithelial 66 inflammatory acne 66 serum PTH 66 venous thromboembolic events 66 immunopathology 66 Peripheral edema 66 elevated creatinine 66 alpha blocker 66 ziconotide 66 gastric adenocarcinoma 66 blood phenylalanine Phe 66 ZYVOX 66 contrast induced nephropathy 66 EBV infection 66 proteoglycan 66 mucocutaneous reactions 66 etomidate 66 thromboembolic 66 hepatic metabolism 66 azole 66 hepatic fibrosis 66 tigecycline 66 bronchial hyperresponsiveness 66 selective inhibition 66 Pseudomonas aeruginosa infections 66 TNFa 66 serum BDNF 66 PROMACTA 66 concomitant medications 66 thiazide 66 tumoral 66 serum uric acid 66 DOXIL 66 IGFBP 3 66 myelosuppressive 66 AZT zidovudine Retrovir 66 hematologic parameters 66 chronic eosinophilic leukemia 66 ertapenem 66 idraparinux 66 O PPDS 66 myocardial ischemia 66 acromegalic patients 66 dopaminergic therapy 66 Kinoid 66 antiangiogenic 66 moderate renal impairment 66 MYCAMINE 66 corticosteroid dose 66 fibrinolysis 66 Nebulized 66 peritumoral brain edema 66 HIV HCV coinfected 66 airway hyper responsiveness 66 PASI scores 66 neurotrophic 66 K ras mutations 66 bovine thrombin 66 Known hypersensitivity 66 PlGF 66 hypereosinophilic syndrome 66 glycated hemoglobin levels 66 lipid lowering therapies 66 hematologic abnormalities 66 atrophic gastritis 66 hydroxymethyl coenzyme 66 postoperative atrial fibrillation 66 Vidaza azacitidine 66 IV bisphosphonates 66 vasoconstrictor 66 left ventricular dysfunction 66 neutropenia thrombocytopenia 66 suppressive therapy 66 Cremophor 66 recurrent genital herpes 66 nonhematologic adverse reactions 66 ara C 66 Ranolazine 66 HES CEL 66 potassium sparing diuretics 66 hyperoxaluria 66 imatinib resistance 66 thalidomide Thalomid 66 FASLODEX 66 antiandrogen 66 alanine aminotransferase ALT 66 liposomal amphotericin B 66 intimal hyperplasia 66 elevated IOP 66 amprenavir 66 INTEGRILIN R 66 antidiabetic drugs 66 pericardial effusion 66 hypercalciuria 66 eculizumab therapy 66 danazol 66 ULORIC 66 systemically administered 66 tumor necrosis 66 lactic acidosis 66 adrenocorticotropic hormone ACTH 66 Glucocorticoids 66 Fondaparinux 66 ALT elevations 66 pulmonary exacerbations 66 von Willebrand factor 66 limiting toxicity 66 virologic response 66 bullous 66 Hypersensitivity reactions 66 antiplatelet medications 66 receptor inhibitor 66 Combination therapy 66 mucosal healing 66 recurrent ischemia 66 imipenem 66 calcineurin inhibitor 66 inotropic 66 ADAMTS# 66 selective modulator 66 leukemia AML 66 azacytidine 66 MDS MPD 66 PREZISTA r 66 EDARBI 66 antiandrogens 66 platelet inhibitor 66 transaminase levels 66 BENICAR HCT 66 nucleoside analogues 66 cidofovir 66 immunosuppressive therapies 66 vasogenic edema 66 rheumatoid arthritis osteoarthritis ankylosing 66 CMV disease 66 ergotamine 66 menadione 66 clomipramine 66 LV dysfunction 66 beta adrenergic 66 growth hormone secretion 66 angioedema 66 microvessel density 66 griseofulvin 66 serum sodium 66 IOP lowering 66 antidepressant efficacy 66 Vidofludimus 66 canakinumab 66 B7 H3 66 serum calcium 66 Gleevec resistant 66 octreotide LAR 66 nadolol 65 PRADAXA 65 heterozygous FH 65 HeFH 65 Orally administered 65 Interferon Beta 65 idarubicin 65 MAGE A3 ASCI 65 cardiovascular morbidity 65 Interferon beta 1b 65 amikacin 65 neurologic deficits 65 thrombus formation 65 atherothrombotic events 65 renal allograft 65 PDGFR 65 immunological responses 65 HPA axis suppression 65 CIPN 65 deep venous thromboses 65 thromboembolism 65 airway hyperreactivity 65 tumorigenicity 65 hyperbilirubinemia 65 mitral regurgitation MR 65 antiemetics 65 mycophenolate mofetil MMF 65 Noxafil 65 ISTODAX 65 degranulation 65 immunosuppressive regimen 65 GI bleeds 65 Myelosuppression 65 reinfarction 65 Lupus nephritis 65 TEAEs 65 plasma renin activity 65 underlying vasculopathy 65 antidiabetic drug 65 indinavir Crixivan 65 sulfasalazine 65 NATRECOR ® 65 ribavirin therapy 65 interferon γ 65 LOVENOX R 65 thiazide diuretic 65 dermatologic toxicities 65 interstitial pneumonia 65 leukocytosis 65 vasospasm 65 chronic thromboembolic pulmonary 65 methicillin susceptible Staphylococcus aureus 65 GnRH agonists 65 hepatic metastases 65 lipid elevations 65 desvenlafaxine succinate 65 antifibrotic 65 chronic idiopathic thrombocytopenic purpura 65 systemic immunosuppressive drugs 65 capillary leak 65 antiinflammatory 65 dots petechiae 65 verapamil 65 aminotransferase levels 65 antidiabetic 65 PEGylated anti 65 trastuzumab Herceptin ® 65 neutropenic fever 65 factor TNF 65 hypocalcemia 65 cytotoxic chemotherapy 65 cytopenia 65 vesicoureteral reflux 65 gastric carcinoma 65 hematological parameters 65 CANCIDAS 65 mu opioid receptor antagonist 65 intravesical 65 renal impairment 65 receiving VELCADE 65 ADPKD 65 recurrent venous thromboembolism 65 complement inhibitor eculizumab 65 CYT# potent vascular disrupting 65 liver histology 65 VIIBRYD 65 antineoplastic 65 TNFalpha 65 fatigue diarrhea nausea 65 Helicobacter pylori infection 65 liver transaminases 65 latent tuberculosis infection 65 Barrett esophagus BE 65 frataxin 65 anemia neutropenia 65 dose limiting toxicities 65 immunosuppression 65 gout flares 65 tirofiban 65 protein excretion 65 acarbose 65 nucleoside analogs 65 non selective NSAIDs 65 urticaria hives 65 hepatic cirrhosis 65 interstitial pneumonitis 65 morphometric vertebral fractures 65 perioperative complications 65 serotonin synthesis 65 mediastinitis 65 serum potassium 65 dopamine reuptake 65 cholelithiasis 65 vasoactive 65 CYP#A# substrate 65 piperacillin tazobactam 65 glucocorticoid therapy 65 hypersensitivity reactions 65 serum creatinine levels 65 E selectin 65 HBeAg positive patients 65 intrahepatic 65 non metastatic osteosarcoma 65 soluble CD# 65 variceal hemorrhage 65 lupus nephritis 65 aminotransferase ALT 65 Candesartan 65 BANZEL 65 PEGylated interferon beta 1a 65 liver decompensation 65 QT QTc 65 myocardial fibrosis 65 Hematologic 65 antithrombotic 65 cytotoxicity 65 HoFH 65 HER2 expression 65 hematological toxicities 65 mucositis 65 atherothrombotic 65 serum aminotransferase levels 65 candesartan cilexetil 65 epithelial tumors 65 Vaprisol 65 QTc intervals 65 hyperphosphatemia 65 antiangiogenic activity 65 elevated serum creatinine 65 Kepivance 65 analgesic effects 65 hematologic adverse 65 CTAP# Capsules 65 diabetic gastroparesis 65 dapsone 65 lactate dehydrogenase 65 PRT# 65 insulin sensitizing 65 effector function 65 FVIII 65 synthase TS 65 MALT lymphoma 65 hypovolemia 65 myeloproliferative diseases 65 immunoreactivity 65 platelet deficiency 65 ganciclovir 65 alpha1 65 severe renal impairment 65 varices 65 intravenous cyclophosphamide 65 hypertrophic scarring 65 lipid lowering agents 65 itraconazole Sporanox 65 esophagitis 65 liver dysfunction 65 HSCT 65 hydroxychloroquine 65 dose colchicine 65 diabetic kidney 65 abdominal adiposity 65 anticholinergic 65 intraoperative complications 65 Fas ligand 65 dalteparin 65 potent CYP#A# inhibitors 65 elevated transaminases 65 prescribed proton pump 65 potentiation 65 lipid parameters 65 macrovascular events 65 serum triglycerides 65 iodixanol 65 topical corticosteroids 65 NF kappaB activation 65 dysuria 65 ritonavir boosted 65 KRAS mutant tumors 65 NS#/#A protease 65 sulindac 65 alkaline phosphatase 65 recombinant interferon 65 colorectal adenocarcinoma 65 generalized seizures 65 hepatic impairment 65 VEGF expression 65 beta blocker therapy 65 Serious adverse reactions 65 pimecrolimus 65 neurotoxicity 65 immunostimulatory effects 65 imatinib mesylate 65 leukoencephalopathy 65 Methylnaltrexone 65 peginterferon alfa 65 Aprotinin 65 Proteinuria 65 prednisone prednisolone 65 serum homocysteine 65 systemic antifungal 65 urinary oxalate 65 intracranial bleeding 65 acetylcysteine 65 systemic bioavailability 65 thyrotropin 65 serum ALT 65 hemoptysis 65 thrombolytic agents 65 renal cysts 65 piroxicam 65 axonal damage 65 nephrogenic fibrosing dermopathy 65 chemosensitivity 65 adrenalectomy 65 microvascular disease 65 Enzastaurin 65 immunosuppressant therapy 65 interferon alfa 2b 65 rilonacept 65 Tolvaptan 65 renoprotective 65 nitrotyrosine 65 erlotinib Tarceva ® 65 elastase 65 oral anticoagulant therapy 65 malignant ascites 65 intratumoral 65 mecamylamine 65 Doxil ® 65 sinus tachycardia 65 VP# [004] 65 periventricular leukomalacia 65 perioperatively 65 viral titers 65 cis retinoic acid 65 triglyceride concentrations 65 ketoconazole 65 proteinuria 64 cardiac repolarization 64 Teriparatide 64 antiplatelet agent 64 antiarrhythmic drug 64 choroidal neovascularization 64 prostanoid 64 MS relapses 64 cardiovascular calcification 64 salivary flow 64 INVEGA ® 64 relapsed MM 64 esophageal carcinoma 64 polyp recurrence 64 MYLOTARG 64 alefacept 64 Fibrillex TM 64 RoACTEMRA 64 myelofibrosis polycythemia vera 64 erythema redness 64 hypertrophic scars 64 Navelbine 64 troglitazone 64 atherogenic dyslipidemia 64 BYSTOLIC 64 trans retinoic acid 64 sorafenib Nexavar 64 azacitidine 64 Primary Hypercholesterolemia 64 G6PD deficiency 64 serum bicarbonate 64 hepatic glucose production 64 solifenacin 64 Postoperative complications 64 peripheral sensory neuropathy 64 selective antagonist 64 pericardial effusions 64 ACE inhibitor ramipril 64 5alpha reductase 64 Lp PLA 2 64 Adalimumab 64 potassium binder 64 Pegylated Liposomal Doxorubicin 64 demonstrated antitumor activity 64 vWD 64 doxorubicin HCl 64 mRCC 64 clodronate 64 HepG2 cells 64 Elitek 64 proinflammatory cytokine 64 alkaline phosphatase ALP 64 calculi 64 aldosterone antagonists 64 pulmonary toxicity 64 anti androgen 64 CIMZIA TM certolizumab pegol 64 QT prolongation 64 elevated bilirubin 64 antiphospholipid syndrome 64 Tumor Necrosis Factor 64 oral JAK1 64 CYP#A# inhibitor 64 liver metastasis 64 pyrimethamine 64 oral antidiabetes 64 leiomyomas 64 busulfan 64 Traficet EN 64 Non inferiority 64 urinary excretion 64 SERCA2a 64 primary hyperparathyroidism 64 interleukin IL -# 64 cutaneous squamous cell carcinoma 64 fulminant hepatic failure 64 recurrent UTI 64 neutrophil count 64 methemoglobinemia 64 seropositive patients 64 chlamydial 64 erythropoiesis 64 Retreatment 64 CYP #D# 64 extrapyramidal side 64 gastrointestinal stromal tumors GIST 64 allogeneic HSCT 64 postsurgical pain 64 basal cell nevus syndrome 64 enalapril 64 Plasmin 64 acid suppressive therapy 64 FUSILEV enhances 64 BAL# [002] 64 thrombi 64 interferon ribavirin 64 carcinoembryonic antigen 64 infarct size 64 benazepril 64 elevated triglyceride levels 64 TNF therapy 64 GP IIb IIIa inhibitors 64 Pemetrexed 64 Celecoxib 64 H2 antagonists 64 paraprotein 64 plasma creatinine 64 immune modulating 64 microtubule targeting 64 plasma lipid 64 pouchitis 64 hepatic dysfunction 64 Helicobacter pylori eradication 64 CIMZIA TM 64 T1DM 64 polymyxin B 64 nasal polyposis 64 angina pectoris 64 Cilostazol 64 post herpetic neuralgia PHN 64 intestinal permeability 64 daunorubicin 64 steatosis 64 H. pylori eradication 64 isoenzyme 64 postoperative mortality 64 IgG4 64 antimetabolite 64 hemoglobin Hb 64 noninfectious uveitis 64 paroxysmal AF 64 post surgical adhesions 64 conventional DMARDs 64 dose cytarabine 64 serotonin reuptake 64 anti leukemic 64 postoperative bleeding 64 acute GVHD 64 abciximab 64 malignant lymphomas 64 relapsed ovarian cancer 64 urate lowering therapy 64 Tekamlo 64 extrapyramidal symptoms EPS 64 anticholinergic agents 64 related hematological toxicity 64 pleurodesis 64 tamsulosin 64 colorectal carcinoma 64 Effexor venlafaxine 64 sclerosing 64 ALT AST 64 euvolemic 64 thrombophlebitis 64 orthostatic hypotension 64 PTHrP 64 VA# [002] 64 retinal vein occlusion 64 TGF ß1 64 MICARDIS ® 64 darunavir r 64 osteosarcomas 64 adriamycin 64 mitogenic 64 histologic subtype 64 fondaparinux 64 Bosentan 64 Exacerbations 64 Cytarabine 64 PTLD 64 MAXALT 64 ACTEMRA TM 64 tumor regressions 64 ACEIs 64 anthracycline chemotherapy 64 VEGF induced 64 cardiac troponin 64 Interferon alpha 64 coagulation abnormalities 64 keloid scarring 64 chronic GVHD 64 cervical lymph nodes 64 antioxidant supplementation 64 ARIXTRA 64 neutropenic 64 Microalbuminuria 64 thrombogenic 64 severe exacerbations 64 QTc interval 64 Zoledronic acid 64 Asymptomatic 64 receiving immunosuppressive therapy 64 anagrelide 64 ARCALYST ® 64 hypervascular tumors 64 potent cytotoxic 64 intracranial hypertension 64 anemia hemoglobin 64 APTIVUS ritonavir 64 hemolysis 64 bronchodilatory 64 dual endothelin receptor antagonist 64 Ischemic 64 recurrent VTE 64 ALA PDT 64 mcg BID 64 antiresorptive 64 antiarrhythmic drugs 64 Azathioprine 64 renal scarring 64 diuretic hydrochlorothiazide 64 pegfilgrastim 64 ACh 64 mucociliary clearance 64 antithrombotic therapy 64 edifoligide 64 eplerenone 64 FasL 64 basiliximab 64 immunosuppressant drug 64 lomitapide 64 ARCOXIA 64 thyrotoxicosis 64 Progressive Multifocal Leukoencephalopathy 64 malignant neoplasms 64 hepatic enzyme 64 urate levels 64 oral mucosa 64 antiplatelet drugs